Change Country
Welcome to LuxembourgWelcome
Please read the important information below before continuing to our website

The Lyxor ETFs on this website may be restricted for certain individuals or in certain countries pursuant to the national regulations applicable to those individuals or countries. It is therefore your responsibility to ensure that you are authorised to invest in the Lyxor ETFs on this website. 


If you are an investor in the United Kingdom, please go to  

If you are an investor in the Netherlands, please go to  

If you are an investor in Italy, please go to  

If you are an investor in Spain, please go to  

If you are an investor in Austria, please go to  

If you are an investor in Germany, please go to   

If you are an investor in Singapore, please go to  

If you are an investor in Switzerland, please go to  

If you are an investor in Belgium, please go to  

If you are an investor in Poland, please go to 

If you are an investor in Norway, please go to

If you are an investor in Denmark, please go to

If you are an investor in Luxembourg, please go to

If you are an investor in Sweden, please go to

If you are an investor in Finland, please go to



The Lyxor ETFs on this website are undertakings for collective investment in transferable securities (UCITS) (i) domiciled in France and approved by the Autorité des Marchés Financiers (AMF) or, (ii) domiciled in Luxembourg, approved by the Commission de Surveillance du Secteur Financier (CSSF) and authorised to market their units or shares in the French Republic in accordance with the notification procedure under Article 93 of Directive 2009/65/EC. Investors should note that the prospectuses of certain Lyxor ETFs under Luxembourg law that have been notified in accordance with this procedure are only available on the website in English. A French translation of these prospectuses can be obtained upon request by sending a letter to Lyxor International Asset Management (“Lyxor”) – 17 Cours Valmy, 92987 Paris La Défense, France.


The information on this website is not intended for persons or entities that are resident, located or registered in jurisdictions that are not authorised to distribute Lyxor ETFs. As a result, the information on this website does not constitute an offer or solicitation to buy or sell units or shares in these ETFs by anyone in any jurisdiction:


(a)   in which such an offer or solicitation is unauthorised;

(b)   in which Lyxor is not qualified to make such an offer or solicitation; or 

(c)   in which it is unlawful to make such an offer or solicitation.


In particular, the Lyxor ETFs on this website are not and will not be registered under the United States Securities Act of 1933, as amended. As such, they may not be offered or sold within the United States of America, except in specific cases where transactions are exempt from registration under the Securities Act. The ETFs listed on this website may not be sold to US citizens or transferred to the United States by any other means, unless this transaction is not subject to any specific registration under US law. 


Any person from a jurisdiction to which the above-mentioned restrictions apply should inform themselves of and observe these restrictions.


This website is intended for commercial purposes and is not regulatory in nature. Although the information provided has been drawn up on the basis of sources considered to be reliable, there is no guarantee that it is accurate, complete or relevant. Some of the information on this website is provided on the basis of market data collected at a specific time and may therefore vary over time. Lyxor advises investors to read the risk factors section of the prospectus and the key investor information document carefully. These documents can be found on the website.


The net asset value (“NAV”) of Lyxor ETFs may at any time be subject to considerable price fluctuations, which in some cases may lead to the loss of all of the capital invested. Investors should note that some ETFs may be sensitive to fluctuations in the exchange rate between their reference currency and that of the underlying index, as well as of the components of the underlying index.


Before investing in a Lyxor ETF, you should carry out your own risk analysis of the product from a legal, tax and accounting perspective, rather than basing your decision solely on the information provided. If necessary, you should consult your own advisers or any other qualified professional. 


Subject to compliance with the legal obligations by which they are bound, Lyxor or any entity within the same group shall not be held liable for any financial or other consequences of an investment in the product. 



By clicking on institutional or individual above, I confirm that I have read and understood the information provided herein, and that I am resident or registered in Luxembourg.


05 Mar 2018

Milestone or millstone for European equities?

With the Catalan crisis stalled, for now at least, all eyes have been on political risk in Italy and some arduous deal-making in Germany. After Sunday’s result, Italy is likely to lurch into some frenzied horse-trading, but where will Merkel’s new coalition of moderates get to and what does it all mean for European equities?  

EMU risk assets have in fact held up pretty well to all of the political stress of recent months, but the economic recovery still seems underpriced. The equity market remains around 15% below the highs of previous cycles.


Italian intrigue

Although the scaremongering did pick up prior to the election, the Five Star Movement was never going to get the majority it needed. A hung parliament was always the likeliest option – a slightly sullied status quo that won’t help progress much-needed reforms or trigger any major disruptions.

The markets and the FTSE MIB might be mollified by a result which doesn’t place the populists directly in power, but it won’t change our view on Italian equities. They may well get left behind this year unless actions taken in the next few days lead to some form of constructive majority government. Parties in Italy aren’t bound to their electoral allies post polling day, so some important decisions still lie ahead.

Should a centre right coalition be struck, we suspect we’ll see more positive progress on reform and therefore expect to adopt a stronger stance on the outlook both for the MIB and EMU risk assets overall. On the other hand, should Five Star swallow its words and form a coalition with the eurosceptic, anti-immigration League party, all bets are off.  


A grand-ish coalition

September’s election in Germany is a distant memory, yet negotiations to form a new government have taken five months – the longest in post-war German history. After renewing their seemingly fractured relationship, Angela Merkel’s conservative CDU party and the initially unwilling Social Democrats (SPD) have finally combined to secure her fourth term in office. The courtship has been more difficult this time around – she has had to surrender control of the key finance, foreign and employment ministries to make the breakthrough.  As a result, the direction the new government will take is hard to call.

The SPD was, essentially, strong-armed into ratifying the deal by voters. Had they not, they were faced with electoral extinction at the hands of the far-right AfD. A rigorous risk-off episode would have been inevitable. The will of the people, and the SPD’s natural will to power, were enough to see them over the line.  

We aren’t certain the SPD’s decision will do much to change what’s a positive outlook for the DAX in the short term. Their “yes” favours domestic demand, German consumers and euro area banks. 

Follow the money

Investors grew more wary of Europe in the latter part of last year given the three-pronged political risk. Appetite has however returned, especially in the US. Flows into eurozone equity ETFs are way ahead of where they were this time last year, despite the volatility of mid-February. Inflows have in fact exceeded those for US equities - potentially signalling the start of an asset allocation shift designed to exploit the valuation gap between the two markets.

Away from ETFs, long/short equity strategies and mutual funds have displayed similar results, with investors attracted by the alpha and beta potential of a two-speed Europe. The weekend’s results may just have made that an even more concrete prospect – provided you are picky. “Macronomic” progress in France and probable debt forgiveness for Greece mean they remain our preferred eurozone markets, but Germany’s outlook has just improved. 


Pick your ground

Signs of such selectivity are already apparent. Country-specific ETFs have enjoyed a sharp rise in inflows, mostly towards Germany. The DAX, with its many exporters, seems to be more driven by swings in EUR/USD and global growth prospects than it is by political concerns. The single currency’s weakness last month was clearly attractive. We expect more good news to follow, provided there’s no great appreciation in the euro from here. 


Lyxor’s European equity range

With Lyxor, you can choose between six broad European or eurozone equity ETFs – among them some of the oldest and largest you can find. And, with TERs starting from just 0.07%, big picture thinking won’t come cheaper. Of course, Europe is our home turf, so we’ve also built a range of single country ETFs built to exploit the best your market has to offer. Home in on household names with large-cap indices like the DAX, CAC or MIB, double up with our daily leveraged products or spot the next big thing with our mid-cap range

Read more on the range

Source: Lyxor Cross Asset & Equity Strategy. All data & opinion as at 5 March 2018 unless otherwise stated. Past performance is no guide to future returns. 

Risk Warning



Fund and charge data: Lyxor ETF, correct as at  05 March 2018.

This document is for the exclusive use of investors acting on their own account and categorized either as “Eligible Counterparties” or “Professional Clients” within the meaning of Markets in Financial Instruments Directive 2004/39/EC. These products comply with the UCITS Directive (2009/65/EC). Société Générale and Lyxor International Asset Management (LIAM) recommend that investors read carefully the “investment risks” section of the product’s documentation (prospectus and KIID). The prospectus and KIID are available free of charge on, and upon request to

The products mentioned are the object of market-making contracts, the purpose of which is to ensure the liquidity of the products on the London Stock Exchange, assuming normal market conditions and normally functioning computer systems. Units of a specific UCITS ETF managed by an asset manager and purchased on the secondary market cannot usually be sold directly back to the asset manager itself. Investors must buy and sell units on a secondary market with the assistance of an intermediary (e.g. a stockbroker) and may incur fees for doing so. In addition, investors may pay more than the current net asset value when buying units and may receive less than the current net asset value when selling them. Updated composition of the product’s investment portfolio is available on In addition, the indicative net asset value is published on the Reuters and Bloomberg pages of the product, and might also be mentioned on the websites of the stock exchanges where the product is listed.

Prior to investing in the product, investors should seek independent financial, tax, accounting and legal advice. It is each investor’s responsibility to ascertain that it is authorised to subscribe, or invest into this product. This document is of a commercial nature and not of a regulatory nature. This material is of a commercial nature and not a regulatory nature. This document does not constitute an offer, or an invitation to make an offer, from Société Générale, Lyxor Asset Management (together with its affiliates, Lyxor AM) or any of their respective subsidiaries to purchase or sell the product referred to herein.

Lyxor International Asset Management (LIAM), société par actions simplifiée having its registered office at Tours Société Générale, 17 cours Valmy, 92800 Puteaux (France), 418 862 215 RCS Nanterre, is authorized and regulated by the Autorité des Marchés Financiers (AMF) under the UCITS Directive (2009/65/EU) and the AIFM Directive (2011/31/EU). LIAM is represented in the UK by Lyxor Asset Management UK LLP, which is authorized and regulated by the Financial Conduct Authority in the UK under Registration Number 435658. Société Générale is a French credit institution (bank) authorised by the Autorité de contrôle prudentiel et de résolution (the French Prudential Control Authority).

Research disclaimer


Lyxor International Asset Management (“LIAM”) or its employees may have or maintain business relationships with companies covered in its research reports. As a result, investors should be aware that LIAM and its employees may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision. Please see appendix at the end of this report for the analyst(s) certification(s), important disclosures and disclaimers. Alternatively, visit our global research disclosure website

Conflicts of interest 

This research contains the views, opinions and recommendations of Lyxor International Asset Management (“LIAM”) Cross Asset and ETF research analysts and/or strategists. To the extent that this research contains trade ideas based on macro views of economic market conditions or relative value, it may differ from the fundamental Cross Asset and ETF Research opinions and recommendations contained in Cross Asset and ETF Research sector or company research reports and from the views and opinions of other departments of LIAM and its affiliates. Lyxor Cross Asset and ETF research analysts and/or strategists routinely consult with LIAM sales and portfolio management personnel regarding market information including, but not limited to, pricing, spread levels and trading activity of ETFs tracking equity, fixed income and commodity indices. Trading desks may trade, or have traded, as principal on the basis of the research analyst(s) views and reports. Lyxor has mandatory research policies and procedures that are reasonably designed to (i) ensure that purported facts in research reports are based on reliable information and (ii) to prevent improper selective or tiered dissemination of research reports. In addition, research analysts receive compensation based, in part, on the quality and accuracy of their analysis, client feedback, competitive factors and LIAM’s total revenues including revenues from management fees and investment advisory fees and distribution fees.

Connect with us on linkedin